HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Hiroyuki Taniguchi Selected Research

pirfenidone

11/2015Risk factors for acute exacerbation of idiopathic pulmonary fibrosis - Extended analysis of pirfenidone trial in Japan.
11/2015Efficacy of pirfenidone and disease severity of idiopathic pulmonary fibrosis: Extended analysis of phase III trial in Japan.
9/2015All-case post-marketing surveillance of 1371 patients treated with pirfenidone for idiopathic pulmonary fibrosis.
5/2015Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis.
1/2011The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial.
1/2011Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Hiroyuki Taniguchi Research Topics

Disease

21Idiopathic Pulmonary Fibrosis
11/2015 - 06/2005
13Interstitial Lung Diseases (Interstitial Lung Disease)
12/2015 - 02/2005
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2014 - 05/2006
8Chronic Obstructive Pulmonary Disease (COPD)
07/2013 - 01/2004
7Bronchiectasis
01/2012 - 06/2002
5Dyspnea (Shortness of Breath)
11/2015 - 10/2009
4Lung Neoplasms (Lung Cancer)
06/2014 - 04/2006
4Asthma (Bronchial Asthma)
08/2012 - 01/2004
3Lung Injury
08/2013 - 04/2006
3Acute Lung Injury
07/2012 - 01/2011
3Fibrosis (Cirrhosis)
07/2012 - 10/2002
3Vascular Diseases (Vascular Disease)
03/2011 - 03/2007
2Connective Tissue Diseases (Connective Tissue Disease)
12/2015 - 01/2014
2Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis)
12/2015 - 03/2007
2Pneumonia (Pneumonitis)
09/2015 - 10/2013
2Pulmonary Hypertension (Ayerza Syndrome)
01/2013 - 03/2011
2Vomiting
06/2008 - 01/2008
2Bronchiolitis
10/2006 - 11/2005
2Inflammation
04/2006 - 10/2002
1Idiopathic Interstitial Pneumonias
12/2015
1Communicable Diseases (Infectious Diseases)
09/2015
1Ischemia
12/2014
1Neutropenia
06/2014
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2014
1Neoplasm Metastasis (Metastasis)
04/2014
1Renal Cell Carcinoma (Grawitz Tumor)
08/2013
1Hepatocellular Carcinoma (Hepatoma)
08/2013
1Nasopharyngitis
07/2013
1Vasculitis (Vasculitides)
12/2012
1Anoxia (Hypoxia)
07/2012
1Leukocytosis (Pleocytosis)
03/2012
1Exanthema (Rash)
01/2012
1Disease Progression
01/2011
1Cough
01/2011
1Respiratory Insufficiency (Respiratory Failure)
01/2010
1Hypopituitarism (Sheehan's Syndrome)
01/2010

Drug/Important Bio-Agent (IBA)

6pirfenidoneIBA
11/2015 - 01/2011
4CollagenIBA
12/2015 - 03/2007
3Carboplatin (JM8)FDA LinkGeneric
12/2010 - 05/2006
2Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2015 - 01/2014
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2015 - 01/2014
2erlotinib (CP 358,774)FDA Link
12/2014 - 01/2012
2Acetylcysteine (Siran)FDA LinkGeneric
12/2014 - 04/2012
2Adrenal Cortex Hormones (Corticosteroids)IBA
08/2012 - 11/2006
2Epidermal Growth Factor Receptor (EGF Receptor)IBA
01/2012 - 04/2006
2Carbon MonoxideIBA
03/2011 - 01/2009
2docetaxel (Taxotere)FDA Link
09/2010 - 05/2006
2salmeterol (Serevent)FDA Link
07/2008 - 11/2006
2T-2328IBA
06/2008 - 01/2008
2tranilast (N 5')IBA
08/2007 - 10/2002
2diazenedicarboxylic acid bis(N'-methylpiperazide)IBA
10/2006 - 11/2005
2Anti-Ulcer AgentsIBA
01/2002 - 01/2002
2ecabetIBA
01/2002 - 01/2002
1AutoantibodiesIBA
12/2015
1OxygenIBA
11/2015
1Anti-Bacterial Agents (Antibiotics)IBA
09/2015
1ThrombomodulinIBA
08/2015
1acetamideIBA
12/2014
12- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA
12/2014
1cefepime (Maxipime)FDA LinkGeneric
06/2014
1Prednisolone (Predate)FDA LinkGeneric
01/2014
1Dihydrotachysterol (AT 10)IBA
10/2013
1Phosphotransferases (Kinase)IBA
08/2013
1Opioid Analgesics (Opioids)IBA
08/2013
1sorafenib (BAY 43-9006)FDA Link
08/2013
1formoterol (Oxis)FDA Link
07/2013
1Budesonide (Pulmicort)FDA LinkGeneric
07/2013
1GasesIBA
01/2013
1Peroxidase (Myeloperoxidase)IBA
12/2012
1glucuronyl glucosamine glycan sulfate (Vessel)IBA
12/2012
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
12/2012
1montelukast (Singulair)FDA Link
08/2012
1Aminophylline (Carine)FDA LinkGeneric
08/2012
1indium-bleomycinIBA
07/2012
1Bleomycin (Blenoxane)FDA LinkGeneric
07/2012
1Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
07/2012
1Doxycycline (Vibramycin)FDA LinkGeneric
07/2012
1C-Reactive ProteinIBA
03/2012
1Polymyxin B (Aerosporin)FDA LinkGeneric
01/2012
1Complementary DNA (cDNA)IBA
06/2011
1sildenafil (Viagra)FDA Link
03/2011
1HMGB1 Protein (HMG1)IBA
01/2011
1CytokinesIBA
01/2011
1gemcitabineFDA Link
12/2010
1Paclitaxel (Taxol)FDA LinkGeneric
09/2010
1PhosphorusIBA
01/2010
1CalciumIBA
01/2010
1Biological Markers (Surrogate Marker)IBA
01/2010
1SodiumIBA
01/2010
1Growth Hormone (Somatotropin)IBA
01/2010

Therapy/Procedure

7Traction
01/2012 - 06/2002
5Drug Therapy (Chemotherapy)
06/2014 - 05/2006
2Activities of Daily Living (ADL)
10/2009 - 04/2009
1Tourniquets
12/2014
1Radiotherapy
06/2014
1Transplantation (Transplant Recipients)
01/2013
1Intravenous Infusions
08/2012
1Hemoperfusion
01/2012
1Adjuvant Chemotherapy
12/2010
1Artificial Respiration (Mechanical Ventilation)
01/2010